New product development

Japan



7 new agreements

Chugai

DepoFoam protein macromolecule formulation

Leading research-driven pharmaceutical company, becoming a subsidiary of Roche

Schering-Plough

Second agreement

Access to enhanced solubilisation technologies

Previous slide

Next slide

Back to first slide

View graphic version